GlassScriptPhysician profile
Mark Mascarenhas
NPI 1841477817
$17,475.78
in general payments reported to CMS, 2019-2025
20 companies · $1,451 in 2025
The $1,451 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $439 · 2021: $909 · 2022: $1,029 · 2023: $2,945 · 2024: $657 · 2025: $1,451.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,921 · Travel and Lodging: $2,132.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,920.50 |
| Travel and Lodging | $2,132.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $10,995.77 | 2019-2025 | Watchman Access System, Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Medtronic, INC. | $2,751.16 | 2022-2025 | Affera Mapping System, Micra, Aurora Ev-Icd Mri Surescan |
| Abbott Laboratories | $1,296.80 | 2019-2025 | Aveir, Ensite, Merlin@Home |
| Biotronik INC. | $369.24 | 2019-2025 | Acticor 7 Vr-T Dx |
| Novartis Pharmaceuticals Corporation | $283.42 | 2019-2025 | |
| Impulse Dynamics (USA) INC. | $262.72 | 2019-2022 | |
| Amgen INC. | $205.91 | 2021-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $146.42 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $144.22 | 2022-2024 | Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $135.11 | 2019-2025 | Lifevest |
| Pfizer INC. | $132.06 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $132.00 | 2020-2025 | Andexxa, Wainua |
| Zoll Respicardia, INC. | $127.19 | 2020 | |
| Alnylam Pharmaceuticals INC. | $104.93 | 2024-2025 | Onpattro, Amvuttra |
| Biosense Webster, INC. | $97.83 | 2020-2025 | Carto 3, Smartablatetm System Rf Generator |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $94.88 | 2022-2023 | |
| Atricure, INC. | $85.91 | 2024 | |
| Esperion Therapeutics, INC. | $49.65 | 2025 | Nexletol |
| Medtronic Vascular, INC. | $36.78 | 2020 | |
| Kestra Medical Technology Services, INC. | $23.78 | 2025 | Assure Wcd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Mascarenhas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.